TrimRx's Blog
Semaglutide Thyroid Cancer — What the Research Really Shows
Semaglutide carries a boxed warning for thyroid C-cell tumors based on rodent studies — but human clinical trials show no confirmed cases. Here’s what
Semaglutide Black Box Warning — What Patients Must Know
Semaglutide carries a black box warning for thyroid C-cell tumor risk. Understand who should avoid GLP-1 therapy and what the evidence actually shows.
Semaglutide Perimenopause — GLP-1 Use During Transition
Semaglutide during perimenopause targets hormonal weight gain and insulin resistance — but timing, dosage adjustments, and metabolic shifts matter
Semaglutide 10mg — Dosing, Results & What to Expect
Semaglutide 10mg isn’t a standard prescription dose — learn what patients actually receive, how titration works, and why starting doses differ from
Semaglutide Fertility — Safe Conception After GLP-1 Use
Semaglutide requires a 2-month washout before conception due to unknown pregnancy effects. Evidence, timing, and fertility impact explained by medical
Semaglutide Lipedema — Evidence, Limits & Real Options
Semaglutide lipedema treatment shows mixed results — GLP-1 medications reduce visceral fat but don’t address subcutaneous lipedema deposits directly.
Semaglutide Hashimoto’s — Can You Use GLP-1s with Thyroid
Semaglutide doesn’t directly interfere with thyroid function in Hashimoto’s patients, but metabolic changes affect dosing. What you need to know before
Semaglutide Cushings — Can GLP-1 Medications Help? | TrimrX
Semaglutide does not treat Cushing’s syndrome directly but may help manage weight gain caused by cortisol dysregulation after surgical remission. Here’s
Semaglutide Shortage — What Patients Need to Know | TrimRx
The semaglutide shortage has lasted since 2023. Here’s what’s happening with supply, how to access medication now, and what alternatives actually work.